We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Cobra Venom Factor and Ketoprofen Abolish the Antitumor Effect of Nerve Growth Factor from Cobra Venom.
- Authors
Osipov, Alexey V.; Terpinskaya, Tatiana I.; Kuznetsova, Tatiana E.; Ryzhkovskaya, Elena L.; Lukashevich, Vladimir S.; Rudnichenko, Julia A.; Ulashchyk, Vladimir S.; Starkov, Vladislav G.; Utkin, Yuri N.
- Abstract
We showed recently that nerve growth factor (NGF) from cobra venom inhibited the growth of Ehrlich ascites carcinoma (EAC) inoculated subcutaneously in mice. Here, we studied the influence of anti-complementary cobra venom factor (CVF) and the non-steroidal anti-inflammatory drug ketoprofen on the antitumor NGF effect, as well as on NGF-induced changes in EAC histological patterns, the activity of lactate and succinate dehydrogenases in tumor cells and the serum level of some cytokines. NGF, CVF and ketoprofen reduced the tumor volume by approximately 72%, 68% and 30%, respectively. The antitumor effect of NGF was accompanied by an increase in the lymphocytic infiltration of the tumor tissue, the level of interleukin 1 β and tumor necrosis factor a in the serum, as well as the activity of lactate and succinate dehydrogenases in tumor cells. Simultaneous administration of NGF with either CVF or ketoprofen abolished the antitumor effect and reduced all other effects of NGF, whereas NGF itself significantly decreased the antitumor action of both CVF and ketoprofen. Thus, the antitumor effect of NGF critically depended on the status of the immune system and was abolished by the disturbance of the complement system; the disturbance of the inflammatory response canceled the antitumor effect as well.
- Subjects
NERVE growth factor; COBRA venom factor; NONSTEROIDAL anti-inflammatory agents; LACTATE dehydrogenase; EHRLICH ascites carcinoma
- Publication
Toxins, 2017, Vol 9, Issue 9, p274
- ISSN
2072-6651
- Publication type
Article
- DOI
10.3390/toxins9090274